Rituximab treatment in pediatric patients with steroid-dependent nephrotic syndrome: A tertiary hospital
Background: Corticosteroids have had a central role in the treatment of nephrotic syndrome. The management of these patients who become dependent to steroids is complex, involving different immunosuppressive drugs patterns. The monoclonal antibody anti CD20, Rituximab, is likely to have beneficial e...
Zapisane w:
Główni autorzy: | Beatriz Guzmán Morais (Autor), Flor Ángel Ordóñez Álvarez (Autor), Fernando Santos Rodríguez (Autor), Silvia Martín Ramos (Autor), Gema Fernández Novo (Autor) |
---|---|
Format: | Książka |
Wydane: |
Elsevier,
2022-02-01T00:00:00Z.
|
Hasła przedmiotowe: | |
Dostęp online: | Connect to this object online. |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy
-
Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome
od: Yewei Chen, i wsp.
Wydane: (2021) -
Rituximab in steroid resistant nephrotic syndrome
od: Agomoni Chaki, i wsp.
Wydane: (2019) -
Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
od: Ji Hyun Kim, i wsp.
Wydane: (2017) -
Hypokalemia After Rituximab Administration in Steroid-Dependent Nephrotic Syndrome: A Case Report
od: Francesco Guzzi, i wsp.
Wydane: (2020) -
Research advances of rituximab in the treatment of children with frequent relapse or steroid-dependent nephrotic syndrome
od: Wen-jing Kang, i wsp.
Wydane: (2024)